TNF and fatty liver disease: Equally important studies from Anna Mae Diehl's laboratory showed that the use of a certain probiotic decreased hepatic steatosis to a similar extent than treatment with an anti-TNF antibody (19) suggesting that both microbes and inflammatory pathways contribute to evolution of hepatic steatosis.